this study is basically to see serum arginase level and total nasal score pre and post treatment with tablet montelukast and tablet levocetrizine and see improvement in allergic rhinitis patients

Evaluation of the Effect of Montelukast Sodium and Levocetrizine on Serum Arginase Levels in Patients with Allergic Rhinitis in a Tertiary Care Center- A Randomized Controlled Trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080336

Enrollment

Registered

2025-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Montelukast sodium 10 mg: Montelukast Sodium 10mg 0-0-1 x 4 weeks Control Intervention1: Levocetrizine 10 mg 0-0-1: Levocetrizine 10 mg 0-0-1 X 4 weeks

Eligibility

Inclusion criteria

Inclusion criteria: Allergic rhinitis

Exclusion criteria

Exclusion criteria: Asthma Polyposis Systemic disease like eosinophilia Pregnancy

Design outcomes

Primary

Measure	Time frame
To Evaluate serum arginase levels in allergic rhinitis patientTimepoint: 4 WEEKS	—

Secondary

Measure	Time frame
To Evaluate total nasal scoresTimepoint: 4 WEEKS	—

Countries

India

Contacts

Public ContactVignesh S

SRM Medical College Hospital and Research Centre

dean.medical.ktr@srmist.edu.in9940036038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026